The use of observational health-care data to identify and report on off-label use of biopharmaceutical products.
Significant efforts are under way to develop analytic surveillance systems that can leverage observational health-care data to monitor biopharmaceutical products. The systems are being designed to identify safety-related events in a post-approval setting, when the products are already on the market.An additional application of such a system would be the use of observational data to help identify and track off-label use of marketed biopharmaceutical products in specific populations.The opportunities and challenges associated with such a system, as well as the underlying data sources themselves, are reviewed in this article.